MERRF/MELAS overlap syndrome: a double pathogenic mutation in mitochondrial tRNA genes

Area of Science:

• Genetics
• Molecular Biology
• Neurology

Background:

• Myoclonic epilepsy with ragged-red fibres (MERRF) and mitochondrial encephalopathy, lactic acidosis and stroke-like episodes (MELAS) are key phenotypes of mitochondrial encephalomyopathy.
• Specific mutations, m.8356T>C (MERRF) and m.3243A>G (MELAS), in mitochondrial tRNA genes are established causes.
• Previous studies on double mitochondrial DNA (mtDNA) mutations remain incomplete.

Observation:

• A family presented with a double mtDNA point mutation (m.8356T>C and m.3243A>G) in mitochondrial tRNA genes.
• Clinical phenotypes ranged from MERRF to MERRF/MELAS overlap syndrome and asymptomatic carriage among four family members.
• The double mutation was heteroplasmic in blood, with varying mutation loads, and showed differential heteroplasmy in muscle tissue.

Findings:

• This is the first documented instance of a double-point mutation in mtDNA associated with both MERRF and MELAS phenotypes.
• The study observed heteroplasmy for both mutations in blood and differential heteroplasmy in muscle, suggesting complex inheritance patterns.
• No other mtDNA mutations were identified in the total mtDNA sequence of the affected family.

Implications:

• The findings suggest a potential sequential development of phenotypes, possibly starting with MERRF and progressing to MELAS in the presence of this double mutation.
• Understanding the heteroplasmy dynamics of double mtDNA mutations is crucial for predicting disease severity and progression.
• This case underscores the importance of comprehensive genetic analysis in mitochondrial disorders to identify complex mutation patterns and their clinical impact.